XBP(XBP)
XBP
Q3 2026 EPS Estimate
$-1.04
Aug 19, 2026 · Reports before open
Revenue Estimate
$198M
FY2028E EPS$3.78
FY2029E EPS$5.96
Analyst Sentiment
Wall St. Consensus
Buy1 analyst·Low coverage
75
Score
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$5.00
+83.8%
Consensus
$5.00
+83.8%
Bull
$5.00
+83.8%
12-Month Target Range1 analyst
$5.00$5.00$5.00
Current $2.72Consensus
Current Price
$2.72
Upside to Consensus
$2.28
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+10.86%
EPS—
FY2028
Rev+8.90%
EPS—
FY2029
Rev+8.25%
EPS+57.67%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $811M | $899M | $979M | $1.06B | $1.15B |
| Low | $811M | $899M | $979M | $1.06B | $1.15B |
| High | $811M | $899M | $979M | $1.06B | $1.15B |
| EBITDA Avg | $176M | $195M | $212M | $230M | $250M |
| Low | $176M | $195M | $212M | $230M | $250M |
| High | $176M | $195M | $212M | $230M | $250M |
| EBIT Avg | $160M | $177M | $193M | $209M | $227M |
| Low | $160M | $177M | $193M | $209M | $227M |
| High | $160M | $177M | $193M | $209M | $227M |
| Net Income Avg | $-53M | $-18M | $44M | $70M | $104M |
| Low | $-53M | $-18M | $44M | $70M | $104M |
| High | $-53M | $-18M | $44M | $70M | $104M |
| EPS Avg | $-4.51 | $-1.51 | $3.78 | $5.96 | $8.88 |
| Low | $-4.51 | $-1.51 | $3.78 | $5.96 | $8.88 |
| High | $-4.51 | $-1.51 | $3.78 | $5.96 | $8.88 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $203M | $213M | $217M | $223M | $223M | $237M |
| Low | $203M | $213M | $217M | $223M | $223M | $237M |
| High | $203M | $213M | $217M | $223M | $223M | $237M |
| EBITDA Avg | $44M | $46M | $47M | $48M | $48M | $51M |
| Low | $44M | $46M | $47M | $48M | $48M | $51M |
| High | $44M | $46M | $47M | $48M | $48M | $51M |
| EBIT Avg | $40M | $42M | $43M | $44M | $44M | $47M |
| Low | $40M | $42M | $43M | $44M | $44M | $47M |
| High | $40M | $42M | $43M | $44M | $44M | $47M |
| Net Income Avg | $-9M | $-5M | $-5M | $-5M | $-4M | $-4M |
| Low | $-9M | $-5M | $-5M | $-5M | $-4M | $-4M |
| High | $-9M | $-5M | $-5M | $-5M | $-4M | $-4M |
| EPS Avg | $-0.76 | $-0.44 | $-0.46 | $-0.41 | $-0.34 | $-0.30 |
| Low | $-0.76 | $-0.44 | $-0.46 | $-0.41 | $-0.34 | $-0.30 |
| High | $-0.76 | $-0.44 | $-0.46 | $-0.41 | $-0.34 | $-0.30 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |